Cognitive remediation therapy in schizophrenia: Cost-effectiveness analysis

Schizophrenia Research

Volumn 120, Issue 1-3, 2010, Pages 217-224

  Patel, Anita ^a   Knapp, Martin ^a,b   Romeo, Renee ^a   Reeder, Clare ^a   Matthiasson, Pall ^a   Everitt, Brian ^a   Wykes, Til ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF ECONOMICS   (United Kingdom)

Author keywords

Cognitive remediation; Cost effectiveness; Psychological therapy

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE REMEDIATION THERAPY; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; INVESTMENT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL CARE; SOCIAL DISABILITY; WORKING MEMORY; ADULT; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; ECONOMICS; FEMALE; FOLLOW UP; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PROBABILITY; PROCEDURES; PSYCHOLOGY; SHORT TERM MEMORY; TIME; TREATMENT OUTCOME;

ADULT; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROBABILITY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954143002     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2009.12.003     Document Type: Article

References (21)

1. Andrews G., Sanderson K., Corry J., Issakidis C., Lapsley H. Cost-effectiveness of current and optimal treatment for schizophrenia. Br. J. Psychiatry 2003, 183:427-435.
2. Briggs A.H., Wonderling D.E., Mooney C.Z. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. Health Econ. 1997, 6(4):327-340.
3. Bryson G., Bell M. Initial and final work performance in schizophrenia: cognitive and symptom predictors. J. Nerv. Ment. Dis. 2003, 191:87-92.
4. Chisholm D., Knapp M.R.J., Knudson H.C., Amaddeo F., Gaite L., van Wijngaarden B. Client socio-demographic and service receipt inventory - European Version: development of an instrument for international research. Epsilon Study 5. Br. J. Psychiatry 2000, 39:s28-s33. the Epsilon Study Group, Suppl.
5. Curtis L. Unit costs of health and social care 2008, University of Kent, Canterbury.
6. Delahunty A., Reeder C., Wykes T. Revised cognitive remediation therapy manual 2002, Institute of Psychiatry, London.
7. Gray R., Leese M., Bindman J., Becker T., Burti L., David A., Gournay K., Kikkert M., Koeter M., Puschner B., Schene A., Thornicroft G., Tansella M. Adherence therapy for people with schizophrenia: European multicentre randomised controlled trial. Br. J. Psychiatry 2006, 189:508-514.
8. Healey A., Knapp M., Astin J., Beecham J., Kemp R., Kirov G., David A. Cost-effectiveness evaluation of compliance therapy for people with psychoses. Br. J. Psychiatry 1998, 172(5):420-424.
9. Kay S.R., Fizbein A., Opler L.A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
10. Knapp M., Mangalore R., Simon J. The global costs of schizophrenia. Schizophr. Bull. 2004, 30:279-293.
11. Kuipers E., Fowler D., Garety P., Chishom D., Freeman D., Dunn G., Bebbington P., Hadley C. London-east Anglia randomised controlled trial of cognitive-behavioural therapy for psychosis. III: Follow-up and economic evaluation at 18months. Br. J. Psychiatry 1998, 173:61-68.
12. McGurk S.R., Twamley E.W., Sitzer D.I., McHugo G.J., Mueser K.T. A meta-analysis of cognitive remediation in schizophrenia. Am. J. Psychiatry 2007, 164:1791-1802.
13. OECD, 2001. OECD 515 statistics on purchasing power parities (). http://www.oecd.org/std/ppp.
14. Patel A., Everitt B., Knapp M., Reeder C., Grant D., Ecker C., Wykes T. Schizophrenia patients with cognitive deficits: factors associated with costs. Schizophr. Bull. 2006, 32:766-785.
15. Penn D.L., Waldheter E.J., Perkins D.O., Mueser K.T., Lieberman J.A. Psychosocial treatment for first-episode psychosis: a research update. Am. J. Psychiatry 2005, 162:2220-2232.
16. Reeder C., Newton E., Frangou S., Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophr. Bull. 2004, 30(1):87-100.
17. Sturm R., Unützer J., Katon W. Effectiveness research and implications for study design: sample size and statistical power. Gen. Hosp. Psychiatry 1999, 21(4):274-283.
18. van Hout B.A., Al M.J., Gordon G.S., Rutten F.F. Costs, effects and C/E-ratios alongside a clinical trial. Health Econ. 1994, 3:309-319.
19. Wechsler D. Wechsler Adult Intelligence Scale: Revised 1981, Harcourt, Brace, Jovanovich, New York.
20. Wykes T., Reeder C., Williams C., Corner J., Rice C., Everitt B. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophr. Res. 2003, 61:163-174.
21. Wykes T., Reeder C., Landau S., Everitt B., Knapp M., Patel A., Romeo R. Cognitive remediation therapy in schizophrenia. Randomised controlled trial. Br. J. Psychiatry 2007, 190:421-427.